$MBVX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in MABVAX THERAPEUTICS HOLDINGS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in MABVAX THERAPEUTICS HOLDINGS, INC.. Get notifications about new insider transactions in MABVAX THERAPEUTICS HOLDINGS, INC. for free.

Page:   1 2 3 4 5 ... 5 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 03 2018MBVXMABVAX THERAPEUTIC ...Varvaro Thomas COption ExerciseM0.0051300
Apr 03 2018MBVXMABVAX THERAPEUTIC ...Varvaro Thomas CBuyM0.00513023,06322.6 K to 23.1 K (+2.27 %)
Feb 23 2018MBVXMABVAX THERAPEUTIC ...Resnick Paul FVICE PRESIDENT, CBOOption ExerciseA2.0480,000163,20080,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...Resnick Paul FVICE PRESIDENT, CBOOption ExerciseA2.0480,000163,20080,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...Option ExerciseA2.04195,000397,800195,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...Option ExerciseA2.04195,000397,800195,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseA2.04195,000397,800195,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseA2.04195,000397,800195,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOOption ExerciseA2.04290,000591,600290,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOOption ExerciseA2.04290,000591,600290,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...Varvaro Thomas COption ExerciseA2.0435,00071,40035,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...Varvaro Thomas COption ExerciseA2.0435,00071,40035,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...EISENBERG JEFFREY FOption ExerciseA2.0435,00071,40035,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...EISENBERG JEFFREY FOption ExerciseA2.0435,00071,40035,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...Cohen Kenneth MOption ExerciseA2.0435,00071,40035,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...Cohen Kenneth MOption ExerciseA2.0435,00071,40035,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...MAIER PAUL VOption ExerciseA2.0435,00071,40035,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...MAIER PAUL VOption ExerciseA2.0435,00071,40035,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...Livingston Philip O.CHIEF SCIENCE OFFIC ...Option ExerciseA2.0435,00071,40035,000
Feb 23 2018MBVXMABVAX THERAPEUTIC ...Livingston Philip O.CHIEF SCIENCE OFFIC ...Option ExerciseA2.0435,00071,40035,000
Jan 24 2018MBVXMABVAX THERAPEUTIC ...EISENBERG JEFFREY FSellS0.8417,99815,11864,55882.6 K to 64.6 K (-21.80 %)
Jan 24 2018MBVXMABVAX THERAPEUTIC ...EISENBERG JEFFREY FSellS0.8717,44415,17682,556100 K to 82.6 K (-17.44 %)
Jan 24 2018MBVXMABVAX THERAPEUTIC ...Varvaro Thomas CSellS0.8417,99615,11767,64585.6 K to 67.6 K (-21.01 %)
Jan 24 2018MBVXMABVAX THERAPEUTIC ...Varvaro Thomas CSellS0.8717,44515,17785,641103.1 K to 85.6 K (-16.92 %)
Jan 24 2018MBVXMABVAX THERAPEUTIC ...MAIER PAUL VSellS0.8417,99915,11968,31486.3 K to 68.3 K (-20.85 %)
Jan 24 2018MBVXMABVAX THERAPEUTIC ...MAIER PAUL VSellS0.8717,44915,18186,313103.8 K to 86.3 K (-16.82 %)
Jan 24 2018MBVXMABVAX THERAPEUTIC ...Cohen Kenneth MSellS0.8417,99615,11778,35596.4 K to 78.4 K (-18.68 %)
Jan 24 2018MBVXMABVAX THERAPEUTIC ...Cohen Kenneth MSellS0.8717,44415,17696,351113.8 K to 96.4 K (-15.33 %)
Jan 18 2018MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...SellS0.9238,05435,010283,703321.8 K to 283.7 K (-11.83 %)
Jan 18 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS0.9259,26354,522536,730596 K to 536.7 K (-9.94 %)
Jan 18 2018MBVXMABVAX THERAPEUTIC ...Resnick Paul FVICE PRESIDENT, CBOSellS0.923,0712,82518,33321.4 K to 18.3 K (-14.35 %)
Jan 18 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS0.9241,87338,523320,013361.9 K to 320 K (-11.57 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseM0.00449,15900
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS0.9611,23210,783361,886373.1 K to 361.9 K (-3.01 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS0.9838,69737,923373,118411.8 K to 373.1 K (-9.40 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS0.9666,55063,888411,815478.4 K to 411.8 K (-13.91 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...BuyM0.00449,1590478,36529.2 K to 478.4 K (+1,537.90 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...Resnick Paul FVICE PRESIDENT, CBOOption ExerciseM0.0029,94400
Jan 16 2018MBVXMABVAX THERAPEUTIC ...Resnick Paul FVICE PRESIDENT, CBOSellS0.9682479121,40422.2 K to 21.4 K (-3.71 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...Resnick Paul FVICE PRESIDENT, CBOSellS0.982,8372,78022,22825.1 K to 22.2 K (-11.32 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...Resnick Paul FVICE PRESIDENT, CBOSellS0.964,8794,68425,06529.9 K to 25.1 K (-16.29 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...Resnick Paul FVICE PRESIDENT, CBOBuyM0.0029,944029,9440 to 29.9 K
Jan 16 2018MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...Option ExerciseM0.00406,38200
Jan 16 2018MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...SellS0.9610,2079,799321,757332 K to 321.8 K (-3.07 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...SellS0.9835,16634,463331,964367.1 K to 332 K (-9.58 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...SellS0.9660,47858,059367,130427.6 K to 367.1 K (-14.14 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...BuyM0.00406,3820427,60821.2 K to 427.6 K (+1,914.55 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...Livingston Philip O.CHIEF SCIENCE OFFIC ...Option ExerciseM0.00100,00000
Jan 16 2018MBVXMABVAX THERAPEUTIC ...Livingston Philip O.CHIEF SCIENCE OFFIC ...SellS0.963,5713,428256,554260.1 K to 256.6 K (-1.37 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...Livingston Philip O.CHIEF SCIENCE OFFIC ...SellS0.9812,30112,055260,125272.4 K to 260.1 K (-4.52 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...Livingston Philip O.CHIEF SCIENCE OFFIC ...SellS0.9621,15520,309272,426293.6 K to 272.4 K (-7.21 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...Livingston Philip O.CHIEF SCIENCE OFFIC ...BuyM0.00100,0000293,581193.6 K to 293.6 K (+51.66 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOOption ExerciseM0.00727,21000
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS0.9618,58217,839595,993614.6 K to 596 K (-3.02 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS0.9864,01562,735614,575678.6 K to 614.6 K (-9.43 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS0.96110,093105,689678,590788.7 K to 678.6 K (-13.96 %)
Jan 16 2018MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOBuyM0.00727,2100788,68361.5 K to 788.7 K (+1,182.97 %)
Jan 12 2018MBVXMABVAX THERAPEUTIC ...Varvaro Thomas COption ExerciseM0.00100,00001,543
Jan 12 2018MBVXMABVAX THERAPEUTIC ...Varvaro Thomas CBuyM0.00100,0000100,0000 to 100 K
Jan 12 2018MBVXMABVAX THERAPEUTIC ...Cohen Kenneth MOption ExerciseM0.00100,00001,543
Jan 12 2018MBVXMABVAX THERAPEUTIC ...Cohen Kenneth MBuyM0.00100,0000100,0000 to 100 K
Jan 12 2018MBVXMABVAX THERAPEUTIC ...EISENBERG JEFFREY FOption ExerciseM0.00100,00001,543
Jan 12 2018MBVXMABVAX THERAPEUTIC ...EISENBERG JEFFREY FBuyM0.00100,0000100,0000 to 100 K
Jan 12 2018MBVXMABVAX THERAPEUTIC ...MAIER PAUL VOption ExerciseM0.00100,00001,543
Jan 12 2018MBVXMABVAX THERAPEUTIC ...MAIER PAUL VBuyM0.00100,0000100,0000 to 100 K
Oct 04 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseA0.00340,4200340,420
Oct 04 2017MBVXMABVAX THERAPEUTIC ...EISENBERG JEFFREY FOption ExerciseA0.0075,790075,790
Oct 04 2017MBVXMABVAX THERAPEUTIC ...Cohen Kenneth MOption ExerciseA0.0075,790075,790
Oct 04 2017MBVXMABVAX THERAPEUTIC ...MAIER PAUL VOption ExerciseA0.0075,790075,790
Oct 04 2017MBVXMABVAX THERAPEUTIC ...Resnick Paul FVICE PRESIDENT, CBOOption ExerciseA0.0022,695022,695
Oct 04 2017MBVXMABVAX THERAPEUTIC ...Livingston Philip O.CHIEF SCIENCE OFFIC ...Option ExerciseA0.0075,790075,790
Oct 04 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...Option ExerciseA0.00307,9990307,999
Oct 04 2017MBVXMABVAX THERAPEUTIC ...Varvaro Thomas COption ExerciseA0.0075,790075,790
Oct 04 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOOption ExerciseA0.00551,1560551,156
Sep 18 2017MBVXMABVAX THERAPEUTIC ...Cohen Kenneth MOption ExerciseA0.0024,210024,210
Sep 18 2017MBVXMABVAX THERAPEUTIC ...Livingston Philip O.CHIEF SCIENCE OFFIC ...Option ExerciseA0.0024,210024,210
Sep 18 2017MBVXMABVAX THERAPEUTIC ...EISENBERG JEFFREY FOption ExerciseA0.0024,210024,210
Sep 18 2017MBVXMABVAX THERAPEUTIC ...Varvaro Thomas COption ExerciseA0.0024,210024,210
Sep 18 2017MBVXMABVAX THERAPEUTIC ...MAIER PAUL VOption ExerciseA0.0024,210024,210
Sep 18 2017MBVXMABVAX THERAPEUTIC ...Resnick Paul FVICE PRESIDENT, CBOOption ExerciseA0.007,24907,249
Sep 18 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...Option ExerciseA0.0098,383098,383
Sep 18 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseA0.00108,7390108,739
Sep 18 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOOption ExerciseA0.00176,0540176,054
Aug 02 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOOption ExerciseS6.293,11919,6190
Aug 02 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOOption ExerciseS5.553,11917,3100
Aug 02 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOBuyP0.004,842070,60165.8 K to 70.6 K (+7.36 %)
Aug 02 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOBuyP1.754,2867,50165,75961.5 K to 65.8 K (+6.97 %)
Aug 02 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseS6.293,11919,6190
Aug 02 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseS5.553,11917,3100
Aug 02 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...BuyP0.004,842038,33433.5 K to 38.3 K (+14.46 %)
Aug 02 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...BuyP1.754,2867,50133,49229.2 K to 33.5 K (+14.68 %)
Aug 02 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...Option ExerciseS6.292,07913,0770
Aug 02 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...Option ExerciseS5.552,07911,5380
Aug 02 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...BuyP0.003,228027,31124.1 K to 27.3 K (+13.40 %)
Aug 02 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...BuyP1.752,8575,00024,08321.2 K to 24.1 K (+13.46 %)
Jun 14 2017MBVXMABVAX THERAPEUTIC ...Cohen Kenneth MOption ExerciseA1.5720,00031,40020,000
Jun 14 2017MBVXMABVAX THERAPEUTIC ...EISENBERG JEFFREY FOption ExerciseA1.5720,00031,40020,000
Jun 14 2017MBVXMABVAX THERAPEUTIC ...MAIER PAUL VOption ExerciseA1.5720,00031,40020,000
Jun 14 2017MBVXMABVAX THERAPEUTIC ...Ravetch Jeffrey V.Option ExerciseA1.5720,00031,40020,000
Jun 14 2017MBVXMABVAX THERAPEUTIC ...Varvaro Thomas COption ExerciseA1.5720,00031,40020,000
May 23 2017MBVXMABVAX THERAPEUTIC ...MAIER PAUL VOption ExerciseA1.8050,00090,00050,000
May 23 2017MBVXMABVAX THERAPEUTIC ...Varvaro Thomas COption ExerciseA1.8050,00090,00050,000
May 23 2017MBVXMABVAX THERAPEUTIC ...EISENBERG JEFFREY FOption ExerciseA1.8050,00090,00050,000
May 23 2017MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTOption ExerciseA1.8050,00090,00050,000
May 23 2017MBVXMABVAX THERAPEUTIC ...Cohen Kenneth MOption ExerciseA1.8050,00090,00050,000
May 23 2017MBVXMABVAX THERAPEUTIC ...Livingston Philip O.CHIEF SCIENCE OFFIC ...Option ExerciseA2.0050,000100,00050,000
May 23 2017MBVXMABVAX THERAPEUTIC ...Ravetch Jeffrey V.Option ExerciseA2.00500,0001,000,000500,000
May 23 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOOption ExerciseA2.00500,0001,000,000500,000
Apr 14 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...SellS2.001,3692,73821,22622.6 K to 21.2 K (-6.06 %)
Apr 14 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.003,8857,77029,20633.1 K to 29.2 K (-11.74 %)
Apr 14 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS2.0010,21620,43361,47371.7 K to 61.5 K (-14.25 %)
Apr 11 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...SellS2.0020040022,59522.8 K to 22.6 K (-0.88 %)
Apr 11 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...SellS2.0040080022,79523.2 K to 22.8 K (-1.72 %)
Apr 11 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...SellS2.0145090223,19523.6 K to 23.2 K (-1.90 %)
Apr 11 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.0020040033,09133.3 K to 33.1 K (-0.60 %)
Apr 11 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.0040080033,29133.7 K to 33.3 K (-1.19 %)
Apr 11 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.0145090233,69134.1 K to 33.7 K (-1.32 %)
Apr 11 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS2.0025050071,68971.9 K to 71.7 K (-0.35 %)
Apr 11 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS2.005601,12071,93972.5 K to 71.9 K (-0.77 %)
Apr 11 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS2.016661,33572,49973.2 K to 72.5 K (-0.91 %)
Apr 06 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...SellS2.158671,86223,64524.5 K to 23.6 K (-3.54 %)
Apr 06 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...SellS2.151,8003,87224,51226.3 K to 24.5 K (-6.84 %)
Apr 06 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...SellS2.251,0002,25026,31227.3 K to 26.3 K (-3.66 %)
Apr 06 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.158671,86234,14135 K to 34.1 K (-2.48 %)
Apr 06 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.151,8003,87235,00836.8 K to 35 K (-4.89 %)
Apr 06 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...SellS2.251,0002,25036,80837.8 K to 36.8 K (-2.64 %)
Apr 06 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS2.151,5013,22373,16574.7 K to 73.2 K (-2.01 %)
Apr 06 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS2.152,4505,27174,66677.1 K to 74.7 K (-3.18 %)
Apr 06 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOSellS2.251,1002,47577,11678.2 K to 77.1 K (-1.41 %)
Apr 04 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...Option ExerciseM0.0015,045015,046
Apr 04 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...BuyM0.0015,045027,31212.3 K to 27.3 K (+122.65 %)
Apr 04 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseM0.0021,064021,063
Apr 04 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...BuyM0.0021,064037,80816.7 K to 37.8 K (+125.80 %)
Apr 04 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOOption ExerciseM0.0040,687040,687
Apr 04 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOBuyM0.0040,687078,21637.5 K to 78.2 K (+108.41 %)
Apr 04 2017MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTOption ExerciseM0.001,54301,543
Apr 04 2017MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTBuyM0.001,54304,4382.9 K to 4.4 K (+53.30 %)
Apr 04 2017MBVXMABVAX THERAPEUTIC ...Cohen Kenneth MOption ExerciseM0.001,54301,543
Apr 04 2017MBVXMABVAX THERAPEUTIC ...Cohen Kenneth MBuyM0.001,54307,5576 K to 7.6 K (+25.66 %)
Apr 04 2017MBVXMABVAX THERAPEUTIC ...MAIER PAUL VOption ExerciseM0.001,54301,543
Apr 04 2017MBVXMABVAX THERAPEUTIC ...MAIER PAUL VBuyM0.001,54303,7622.2 K to 3.8 K (+69.54 %)
Apr 04 2017MBVXMABVAX THERAPEUTIC ...Varvaro Thomas COption ExerciseM0.001,54301,543
Apr 04 2017MBVXMABVAX THERAPEUTIC ...Varvaro Thomas CBuyM0.001,54303,0861.5 K to 3.1 K (+100.00 %)
Apr 04 2017MBVXMABVAX THERAPEUTIC ...Ravetch Jeffrey V.Option ExerciseM0.001,54301,543
Apr 04 2017MBVXMABVAX THERAPEUTIC ...Ravetch Jeffrey V.BuyM0.001,54303,0861.5 K to 3.1 K (+100.00 %)
Feb 08 2017MBVXMABVAX THERAPEUTIC ...MAFFUID PAUL WEXECUTIVE VICE PRES ...Option ExerciseA2.99100,000299,000100,000
Feb 08 2017MBVXMABVAX THERAPEUTIC ...HANSON GREGORY PCHIEF FINANCIAL OFF ...Option ExerciseA2.9975,000224,25075,000
Feb 08 2017MBVXMABVAX THERAPEUTIC ...Resnick Paul FVICE PRESIDENT, CBOOption ExerciseA2.9935,000104,65035,000
Feb 08 2017MBVXMABVAX THERAPEUTIC ...HANSEN JOHN DAVIDPRESIDENT AND CEOOption ExerciseA2.99250,000747,500250,000
Jan 03 2017MBVXMABVAX THERAPEUTIC ...Livingston Philip O.CHIEF SCIENCE OFFIC ...Option ExerciseA3.387002,366700

Page:   1 2 3 4 5 ... 5 next >

Contact us | Follow us on Twitter